Stokes Capital Advisors’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.82M Sell
26,071
-4,771
-15% -$865K 0.82% 47
2026
Q1
$4.54M Sell
30,842
-4,379
-12% -$712K 1.02% 41
2025
Q4
$6.86M Sell
35,221
-910
-3% -$217K 1.57% 30
2025
Q3
$10.2M Sell
36,131
-7,883
-18% -$2.01M 2.36% 14
2025
Q2
$9.62M Buy
44,014
+934
+2% +$151K 2.36% 12
2025
Q1
$6.02M Buy
43,080
+39,245
+1,023% +$6.39M 1.53% 37
2024
Q4
$639K Buy
3,835
+1,107
+41% +$197K 0.17% 60
2024
Q3
$465K Buy
+2,728
New +$395K 0.12% 62

Other funds holding ORCL

Stokes Capital Advisors's ORCL Position: Q2 2026 in Review

Stokes Capital Advisors reduced its Oracle (ORCL) stake by 15% in Q2 2026, selling an estimated $865K and leaving 26,071 shares worth $3.82M. The position accounts for 0.82% of the portfolio, ranked #47.

Stokes Capital Advisors first reported a position in ORCL in Q3 2024 and has held it in 8 quarters since. The position peaked at $10.2M in Q3 2025. 1,158 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

  • Stokes Capital Advisors held 26,071 shares of Oracle worth $3.82M as of Q2 2026.
  • Stokes Capital Advisors sold 4,771 Oracle shares in Q2 2026, an estimated $865K.
  • Oracle made up 0.82% of Stokes Capital Advisors's portfolio in Q2 2026, its #47 holding.
  • Stokes Capital Advisors first reported a position in Oracle in Q3 2024 and has held it in 8 quarters since.
  • Stokes Capital Advisors's Oracle position peaked at $10.2M in Q3 2025.
  • 1,158 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on Stokes Capital Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.